Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.


Results 1-6 of 6
  • previous
  • 1
  • next
Item hits:
Issue DateTitleAuthor(s)
1-Jan-2017Treatment-stage migration maximizes survival outcomes in patients with hepatocellular carcinoma treated with sorafenib: an observational studyYen, C; Sharma, R; Rimassa, L; Arizumi, T; Bettinger, D, et al
1-Sep-2016The ALBI grade provides objective hepatic reserve phenotyping across each BCLC stage of hepatocellular carcinoma.Pinato, DJ; Sharma, R; Yen, C; Arizumi, T; Kubota, K, et al
25-Apr-2017Review article: delivering precision oncology in intermediate-stage liver cancerPinato, DJ; Howell, J; Ramaswami, R; Sharma, R; The Academy of Medical Sciences
2-Mar-2017On-target sorafenib toxicity predicts improved survival in hepatocellular carcinoma: a multi-centre, prospective studyHowell, J; Pinato, DJ; Ramaswami, R; Bettinger, D; Arizumi, T, et al
14-Feb-2017Integration of the cancer-related inflammatory response as a stratifying biomarker of survival in hepatocellular carcinoma treated with sorafenib.Howell, J; Pinato, DJ; Ramaswami, R; Arizumi, T; Ferrari, C, et al
1-Jul-2019Identification of mutations in circulating cell-free tumour DNA as a biomarker in hepatocellular carcinomaHowell, J; Atkinson, SR; Pinato, DJ; Knapp, S; Ward, C, et al